The role of sodium-glucose co-transporter 2 protein inhibitors in heart failure: more than an antidiabetic drug?

This study shows that SGLT2 inhibitors are a safe and effective medication in the setting of HFrEF and has been shown to reduce symptoms of heart failure thus improving quality of life and reducing admissions due to heart failure and cardiovascular mortality.